top of page

​

​

Our

Pipeline

Oncology

Discovery Research

Candidate Selection

IND Enabling

Phase I

STING Agonist

HPK1 Inhibitor

IDO/TDO Dual Inhibitor

ACSS2 Inhibitor

Undisclosed Kinase

Inflammation

Discovery Research

Candidate Selection

IND Enabling

Phase I

STING Antagonist

Drug Delivery

Discovery Research

Candidate Selection

IND Enabling

Phase I

ADC

Pro-Drug

Vaccine Adjuvant

Discovery Research

Candidate Selection

IND Enabling

Phase I

STING Agonist

IDO/TDO Dual Inhibitor

bottom of page